Kurt Gustafson
Director of Finance/CFO bij OMNIAB, INC.
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Kurt Gustafson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
XENCOR, INC. | Director/Board Member | 25-07-2014 | - |
Independent Dir/Board Member | 25-07-2014 | - | |
OMNIAB, INC. | Director of Finance/CFO | 01-03-2022 | - |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Director of Finance/CFO | 01-03-2022 | - |
Loopbaan van Kurt Gustafson
Eerdere bekende functies van Kurt Gustafson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CHROMADEX CORPORATION | Director/Board Member | 21-10-2016 | 16-06-2022 |
Independent Dir/Board Member | 21-10-2016 | 16-06-2022 | |
SPECTRUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 05-06-2013 | - |
Director of Finance/CFO | 05-06-2013 | 18-03-2022 | |
Investor Relations Contact | 05-06-2013 | 18-03-2022 | |
HALOZYME THERAPEUTICS, INC. | Director of Finance/CFO | 20-04-2009 | 20-05-2013 |
Corporate Officer/Principal | 06-05-2009 | 20-05-2009 | |
Corporate Secretary | 09-05-2011 | 08-05-2012 | |
AMGEN INC. | Director of Finance/CFO | 01-01-1991 | 01-01-2009 |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Director of Finance/CFO | 01-01-2004 | 01-01-2006 |
Amgen International AG | Director of Finance/CFO | - | - |
Treasurer | - | - | |
░░░░░░░ ░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Kurt Gustafson
University of California, Los Angeles | Masters Business Admin |
North Park University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Nederland | 2 |
Zwitserland | 2 |
Operationeel
Director of Finance/CFO | 7 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 6 |
---|---|
AMGEN INC. | Health Technology |
SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
XENCOR, INC. | Health Technology |
CHROMADEX CORPORATION | Health Technology |
OMNIAB, INC. | Commercial Services |
Bedrijven in privébezit | 4 |
---|---|
Horwath Velez & Co. PSC
Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington. | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The private company is based in Breda, Netherlands. | Distribution Services |
Amgen International AG | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA. | Health Technology |
- Beurs
- Insiders
- Kurt Gustafson
- Ervaring